Mobic and Movicol drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Mobic (meloxicam) and Movicol (polyethylene glycol 3350). Common drug interactions include adverse event among females and coronary artery disease among males.
The phase IV clinical study analyzes what interactions people have when they take Mobic and Movicol. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.
What is Mobic?
Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 26,684 Mobic users. Check the latest studies of Mobic.
What is Movicol?
Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
22 people who take Mobic and Movicol together, and have interactions are studied.

What are the common drug interactions of Mobic and Movicol, by gender? *:
female:
- Adverse event
- Ankylosing spondylitis (type of arthritis affecting the spine)
- Anorexia nervosa (psychological disorder-eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
- Asthenia (weakness)
- Cachexia (loss of weight)
- Decreased interest
- Depression
- Discomfort
- Fibromyalgia (a long-term condition which causes pain all over the body)
- Hospitalisation
male:
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Death
- Rash pruritic (redness with itching)
- Urticaria (rash of round, red welts on the skin that itch intensely)
What are the common drug interactions of Mobic and Movicol, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Adverse event
- Ankylosing spondylitis (type of arthritis affecting the spine)
- Anorexia nervosa (psychological disorder-eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
- Asthenia (weakness)
- Cachexia (loss of weight)
- Decreased interest
- Depression
- Discomfort
- Fatigue (feeling of tiredness)
- Fibromyalgia (a long-term condition which causes pain all over the body)
50-59:
- Rash generalised (rash on most of body parts)
60+:
- Cystitis (inflammation of the wall of the bladder)
- Dyspnoea (difficult or laboured respiration)
- Affect lability (emotional incontinence)
- Bacterial infection
- Diarrhoea
- Dyskinesia (abnormality or impairment of voluntary movement)
- Fall
- Fatigue (feeling of tiredness)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- General physical health deterioration (weak health status)
What are the existing conditions these people have? *
- Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 22.73%
- Automatic Bladder (nerve impulses between the bladder and the spinal cord remain intact and the bladder can be trained to empty by reflex (spastic) action): 5 people, 22.73%
- Back Pain: 4 people, 18.18%
- Multiple Myeloma (cancer of the plasma cells): 4 people, 18.18%
- Joint Pain: 3 people, 13.64%
- Headache (pain in head): 3 people, 13.64%
- Depression: 3 people, 13.64%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 13.64%
- Nausea (feeling of having an urge to vomit): 3 people, 13.64%
- Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 3 people, 13.64%
* Approximation only. Some reports may have incomplete information.
Do you take Mobic and Movicol?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Mobic and Movicol:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Mobic:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Movicol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mobic and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Movicol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on meloxicam and polyethylene glycol 3350 (the active ingredients of Mobic and Movicol, respectively), and Mobic and Movicol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Letrozole cause Sinus Tachycardia? - 14 seconds ago
- Drug interactions of Vfend and Bisacodyl - a minute ago
- Drug interactions of Allopurinol and Pamelor - a minute ago
- Could Innohep cause Nephrotic Syndrome? - a minute ago
- Drug interactions of Zestril and Rosiglitazone - a minute ago
- Could Lanoxin cause Movement - Uncoordinated? - a minute ago
- Could Nucala cause Breath Sounds Abnormal? - 2 minutes ago
- Heart Palpitations in Antitussive, how severe and when it was recovered? - 2 minutes ago
- Could Acetazolamide cause Meningitis Aseptic? - 2 minutes ago
- Could Eliquis cause Bone Lesion? - 2 minutes ago